Compare Biogen Inc (BIIB) vs Eni SpA (E) Price & Performance

Biogen IncTrade

Eni SpATrade

Price performance (Past 24H)

Key statistics

Biogen Inc vs Eni SpA — how do they compare? Biogen Inc trades at $191.9 (market cap $30.86B), while Eni SpA trades at $49.51 (market cap $71.48B). The key difference: Eni SpA is far larger — about 2.3× Biogen Inc's market cap, and Eni SpA pays a 4.94% dividend while Biogen Inc pays none. Which is the better fit depends on your goals.

	BIIB	E
Market Cap	$30.86B	$71.48B
Sector	Health	Energy
52-Week High	$216.63	$57.61
52-Week Low	$122.68	$32.93
Enterprise Value	$33.14B	$90.39B
Dividend Yield	—	4.94%

View details →View details →

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

BIIB

Real-world study shows 83% of early Alzheimer's patients stable or improved on LEQEMBI over 17 monthsPRNewsWire · 22 hours agoBullish Biogen's diranersen shows promising Phase 2 results slowing early Alzheimer's decline and reducing tau protein.GlobeNewsWire · 1 day agoBullish FDA approves LEQEMBI IQLIK, first at-home weekly injection for early Alzheimer's treatmentPRNewsWire · 1 day agoBullish View details →

Enterprise Group expands natural gas power projects with two new Canadian oil and gas clients.Newsfile Corp · 2 days agoBullish View details →

About Biogen Inc

Biogen and Idec merged in 2003, combining forces to market Biogen's multiple sclerosis drug Avonex and Idec's cancer drug Rituxan. Today, Rituxan and next-generation antibody Gazyva are marketed via a collaboration with Roche. Biogen also markets novel MS drugs Plegridy, Tysabri, Tecfidera, and Vumerity. In Japan, Biogen's MS portfolio is co-promoted by Eisai. Hemophilia therapies Eloctate and Alprolix (partnered with SOBI) were spun off as part of Bioverativ in 2017. Biogen has several drug candidates in phase 3 trials in neurology and neurodegenerative diseases and has launched Spinraza with partner Ionis. Aduhelm was approved as the firm's first Alzheimer's disease therapy in June 2021.

About Eni SpA

Eni is an integrated oil and gas company that explores for, produces, and refines oil around the world. In 2021, the company produced 0.8 million barrels of liquids and 4.6 billion cubic feet of natural gas per day. At end-2021, Eni held reserves of 6.6 billion barrels of oil equivalent, 49% of which are liquids. The Italian government owns a 30.1% stake in the company. Eni is placing its renewable and low-carbon business in a separate entity, Plentitude